AgriNetica and Nurtured Nuts plant allergen-less peanuts in Georgia

By AI, Created 10:18 AM UTC, May 20, 2026, /AGP/ – AgriNetica and Nurtured Nuts say they have planted USDA-approved allergen-less peanuts at a classified agricultural site in Georgia, moving the project from lab development to field cultivation. The companies say the first outdoor grow could help support clinical trials, regulatory review and a commercial launch later this year, pending FDA approval.

Why it matters: - The planting is a key step toward a peanut product designed to be safe for the more than 6.1 million Americans with peanut allergies. - The companies are moving from laboratory work to field cultivation, which is a major test of whether the genetics hold up outside controlled conditions. - The project could open a new category of peanut product if regulators ultimately approve the allergen-less claims.

What happened: - AgriNetica and Nurtured Nuts announced that allergen-less peanuts were successfully planted at a classified agricultural site in Georgia on May 5, 2026. - The companies said the planting is the first outdoor, field-scale grow under the Nurtured Nuts initiative. - The product is expected to be in hand later this year.

The details: - AgriNetica is the U.S. division of BetterSeeds, an Israeli biotech company focused on CRISPR-based crop science. - The partnership between AgriNetica and Nurtured Nuts was first announced in November 2025. - AgriNetica developed the peanut using proprietary second-generation gene-editing technology. - The companies say the peanut has dramatically reduced allergens while preserving nutrition, taste and versatility. - Georgia was chosen because of its climate, agricultural infrastructure and peanut-growing expertise. - The state is the leading peanut-producing state in the U.S. - The upcoming harvest is expected to support clinical trials, regulatory review, commercial R&D and customer validation. - Nurtured Nuts is also expanding partnerships with the USDA, FDA, BrandVault360 and WISECode to scale marketing information and presence. - The companies included a note that all allergen-less claims are pending FDA approval. - The release links to Nurtured Nuts on LinkedIn and Nurtured Nuts on Instagram.

Between the lines: - The move to a field site suggests the companies want to show the crop can perform beyond the lab before broader commercialization. - The FDA approval note signals the product still faces a regulatory hurdle even as the companies frame the planting as a milestone. - The Georgia site choice points to a strategy of testing the product in the center of U.S. peanut production rather than in a less relevant environment.

What’s next: - The companies say the next harvest will feed additional clinical, regulatory and commercial work. - Nurtured Nuts expects to have the product in hand later this year. - Any consumer launch will depend on the outcome of FDA review of the allergen-less claims.

The bottom line: - AgriNetica and Nurtured Nuts have moved their allergen-less peanut project from the lab to the field, but FDA approval remains the key gate before the product can reach consumers.